FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)

View source ↗

Summary

FDA approved a Supplemental Application for Valium (diazepam) from Roche Laboratories Inc., indicating an approved change or addition to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Epilepsy
• Spasticity

Drugs mentioned

• VALIUM (DIAZEPAM)

Snippet

SUPPL AP for VALIUM (DIAZEPAM)